Orthocell Ltd
ASX:OCC

Watchlist Manager
Orthocell Ltd Logo
Orthocell Ltd
ASX:OCC
Watchlist
Price: 0.64 AUD -3.76% Market Closed
Market Cap: 153m AUD
Have any thoughts about
Orthocell Ltd?
Write Note

Orthocell Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Orthocell Ltd
Operating Income Peer Comparison

Comparables:
MSB
CSL
CUV
TLX
PYC

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Orthocell Ltd
ASX:OCC
Operating Income
-AU$10.2m
CAGR 3-Years
4%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Mesoblast Ltd
ASX:MSB
Operating Income
-$66.9m
CAGR 3-Years
10%
CAGR 5-Years
5%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Operating Income
$3.8B
CAGR 3-Years
7%
CAGR 5-Years
9%
CAGR 10-Years
9%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Operating Income
AU$57.1m
CAGR 3-Years
24%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Telix Pharmaceuticals Ltd
ASX:TLX
Operating Income
AU$17.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
PYC Therapeutics Ltd
ASX:PYC
Operating Income
-AU$37.6m
CAGR 3-Years
-26%
CAGR 5-Years
-40%
CAGR 10-Years
-22%

See Also

What is Orthocell Ltd's Operating Income?
Operating Income
-10.2m AUD

Based on the financial report for Jun 30, 2024, Orthocell Ltd's Operating Income amounts to -10.2m AUD.

What is Orthocell Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-4%

Over the last year, the Operating Income growth was -9%. The average annual Operating Income growth rates for Orthocell Ltd have been 4% over the past three years , -4% over the past five years .

Back to Top